January 01, 1970
Latest press releases
September 21, 2021BICO Launches 3D Bioprinting contract research offering from CELLINK, MatTek and Visikol
September 15, 2021BICO has acquired HUREL micro liver technologies to offer the market's most comprehensive liver in vitro services
September 7, 2021BICO welcomes Erica Bell as Chief People Officer as company nears 1,000 employees globally
August 27, 2021BICO has acquired Advanced BioMatrix, an innovative company focused on 3D applications, to, together, ensure a market leading portfolio of bioinks and reagents
August 23, 2021DISPENDIX welcomes Petros Apostolopoulos as new CEO to strengthen position as leading liquid handling and lab automation company
August 18, 2021Introducing BICO: The Global Leader in the Bio Convergence Revolution
August 18, 2021RegulatoryInterim report January-June 2021: Increased net sales of 628% driven by M&A and organic growth of 95% and positive EBITDA in Q2.
August 13, 2021Change of name and short name (ticker) for shares in CELLINK AB (publ)
August 12, 2021The name change has been registered: CELLINK AB (publ) new name is BICO Group AB (publ)
August 12, 2021Invitation to earnings call for interim report January-June 2021
August 6, 2021RegulatoryBulletin from Extraordinary General Meeting in CELLINK AB (publ)
July 30, 2021RegulatoryCELLINK announces an increase in number of shares and votes
July 19, 2021CELLINK launches the S.NEST, a high-throughput microbioreactor with real-time monitoring to ensure maximum cell growth and streamlined workflows
July 7, 2021CELLINK has initiated the process of changing name to BICO
July 7, 2021RegulatoryNotice of Extraordinary General Meeting of CELLINK AB (publ)
July 6, 2021Visikol partners with MatTek to leverage their advanced cell culture models in its suite of drug discovery services
June 30, 2021CELLINK completes the acquisition of Discover Echo
June 30, 2021CELLINK has been granted its first patent of robotic systems for personalized and automated aesthetic medical procedures
June 30, 2021RegulatoryCELLINK announces an increase in number of shares and votes
June 29, 2021CELLINK has been granted a patent for "Cellulose Nanofibrillar Bioink for 3D Bioprinting for Cell Culturing, Tissue Engineering and Regenerative Medicine Applications" from European Patent Office
June 26, 2021RegulatoryCELLINK has entered into an agreement to acquire Discover Echo Inc., an innovative and revolutionary microscopy company
June 23, 2021CELLINKs EpiDerm ™ skin model has been approved by the OECD as a stand-alone in-vitro test method for phototoxicity
May 31, 2021CELLINK completes the acquisition of Nanoscribe
May 24, 2021CELLINK Bioprinting moves to Entré Kallebäck
May 20, 2021CELLINK has acquired Visikol, a contract research services company focused on advanced imaging, 3D cell culture assays and digital pathology
May 19, 2021RegulatoryCELLINK has entered into an agreement to acquire Nanoscribe, a market leading 3D bioprinting company based on Two-Photon Polymerization technology
May 12, 2021RegulatoryInterim report January-March 2021: High organic growth, strengthened gross margin, and strategic acquisitions
April 30, 2021RegulatoryCELLINK announces an increase in number of shares and votes
April 26, 2021RegulatoryBulletin from Annual General Meeting in CELLINK AB (publ)
April 14, 2021CELLINK receives the prestigious gold award for the BIO X6 and wins two design excellence awards for the C.WASH and UP.SIGHT at the iF Design Awards 2021.
April 6, 2021CELLINK and UPM Biomedicals has formed a collaboration for ground-breaking 3D bioprinting developments
March 31, 2021Invitation to CELLINKs digital Capital Markets Day on May 12, 2021 with focus on the bioconvergence agenda
March 31, 2021RegulatoryCELLINK announces an increase in number of shares and votes
March 26, 2021RegulatoryNotice of Annual General Meeting of CELLINK AB (publ)
March 23, 2021BIO X6 wins prestigious Red Dot Design Award for outstanding design quality
March 22, 2021CELLINK completes the acquisition of MatTek Corporation
March 17, 2021RegulatoryCELLINK publishes Annual Report 2019/2020
March 15, 2021CELLINK launches the BIO MDX Series , a scaled-up revolution in biomedical manufacturing
March 12, 2021RegulatoryCELLINK AB announces the completion of the offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an overall amount of SEK 3.0 billion
March 11, 2021RegulatoryCellink AB announces an offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an expected amount of SEK 2.75 billion
March 10, 2021Correction in CELLINK’s Swedish press release
March 10, 2021RegulatoryCELLINK has entered into an agreement to acquire MatTek, the global leader in in-vitro technology and alternative drug testing models
March 1, 2021CELLINK completes the acquisition of Ginolis Oy
February 25, 2021RegulatoryYear-end report 19/20: Continued strong organic growth, positive result and strategic investments for the future
February 19, 2021Invitation to CELLINK’s earnings call – Year-end Report 2019/2020
February 15, 2021RegulatoryCELLINK has entered into an agreement to acquire the advanced robotics and diagnostics automation company Ginolis
February 8, 2021CELLINK announce distribution agreement including new products for Single-Cell RNA Sequencing and NGS Library Preparation
January 28, 2021CELLINK announces third year extension of collaboration with a global biopharmaceutical company for drug discovery
January 25, 2021CELLINK launches UP.SIGHT, a rapid, all-in-one imager and single-cell dispenser that offers double assurance of clonality
January 19, 2021CELLINK to bring Livecyte high content live cell imager to a wider audience